Total Payments
$5,606
2024 Payments
$1,609
Companies
46
Transactions
344
Medicare Patients
721
Medicare Billing
$97,397
Payment Breakdown by Category
Food & Beverage$5,592 (99.8%)
Education$13.89 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,592 | 343 | 99.8% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $803.48 | 99 | $0 (2024) |
| Lilly USA, LLC | $754.32 | 46 | $0 (2024) |
| ABBVIE INC. | $441.21 | 18 | $0 (2024) |
| Radius Health, Inc. | $277.93 | 13 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $264.92 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $235.48 | 9 | $0 (2024) |
| Antares Pharma, Inc. | $219.44 | 12 | $0 (2024) |
| Mannkind Corporation | $195.89 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $195.31 | 4 | $0 (2024) |
| Amphastar Pharmaceuticals, Inc. | $185.30 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,609 | 81 | Lilly USA, LLC ($219.83) |
| 2023 | $1,228 | 77 | Lilly USA, LLC ($253.74) |
| 2022 | $952.27 | 68 | Novo Nordisk Inc ($206.51) |
| 2021 | $702.03 | 46 | Mannkind Corporation ($138.11) |
| 2020 | $321.51 | 35 | Novo Nordisk Inc ($145.62) |
| 2019 | $492.08 | 24 | Alexion Pharmaceuticals, Inc. ($124.29) |
| 2018 | $300.73 | 13 | AbbVie, Inc. ($143.29) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Automated insulin delivery system | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.22 | General |
| 11/25/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $56.76 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.95 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Rare Disease | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Endocrinology | ||||||
| 09/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 134 | 231 | $52,601 | $19,239 |
| 2022 | 3 | 137 | 253 | $53,460 | $20,884 |
| 2021 | 5 | 182 | 276 | $66,976 | $28,015 |
| 2020 | 8 | 268 | 340 | $73,613 | $29,260 |
Total Patients
721
Total Services
1,100
Medicare Billing
$97,397
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 164 | $38,767 | $14,650 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 29 | $9,274 | $3,553 | 38.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 18 | 38 | $4,560 | $1,035 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 181 | $39,730 | $15,586 | 39.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 29 | $8,570 | $4,130 | 48.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 19 | 43 | $5,160 | $1,168 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 167 | $36,657 | $15,987 | 43.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $12,749 | $5,156 | 40.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 24 | $7,092 | $3,278 | 46.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $6,758 | $2,721 | 40.3% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 15 | 31 | $3,720 | $871.80 | 23.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 146 | $29,278 | $11,566 | 39.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 54 | 54 | $22,177 | $9,068 | 40.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 38 | 38 | $12,415 | $4,902 | 39.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 24 | $6,130 | $2,217 | 36.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 20 | $2,860 | $1,230 | 43.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 16 | 16 | $320.00 | $152.32 | 47.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 22 | 23 | $138.00 | $70.84 | 51.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 19 | 19 | $294.00 | $53.34 | 18.1% |
About Dr. Nina Le, MD
Dr. Nina Le, MD is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1962781666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nina Le, MD has received a total of $5,606 in payments from pharmaceutical and medical device companies, with $1,609 received in 2024. These payments were reported across 344 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($5,592).
As a Medicare-enrolled provider, Le has provided services to 721 Medicare beneficiaries, totaling 1,100 services with total Medicare billing of $97,397. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 08/11/2011
- Last Updated 02/14/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962781666
Products in Payments
- Ozempic (Drug) $567.49
- BAQSIMI (Drug) $334.33
- TRULICITY (Drug) $271.21
- UNITHROID (Drug) $264.92
- SYNTHROID (Drug) $233.92
- XYOSTED (Drug) $197.45
- AFREZZA (Drug) $195.89
- JARDIANCE (Drug) $193.34
- Tymlos (Drug) $188.79
- Synthroid (Drug) $183.07
- MOUNJARO (Drug) $152.39
- EVENITY (Biological) $117.44
- FARXIGA (Drug) $115.45
- Omnipod (Device) $104.18
- iLet Bionic Pancreas (Device) $100.05
- Rybelsus (Drug) $95.59
- Wegovy (Drug) $95.41
- Tymlos (Biological) $89.14
- ZEPBOUND (Drug) $86.28
- t:slim X2 Insulin Pump with Control-IQ (Device) $86.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Internal Medicine $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Internal Medicine $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M